The frequency of, risk factors for, and outcome of polyclonal gram-negative bacteremia are still unknown. We investigated them in a prospective cohort study of patients for whom a blood culture yielded у1 species of gram-negative aerobic rod. For each patient, pulsed field gel electrophoresis (PFGE) was performed on 4 colonies of each morphologic type. Episodes of bacteremia were considered polyclonal if caused by 11 PFGE type of the same species. Ten (6.5%) of 153 investigated patients had polyclonal bacteremia. Bacteremia due to nonfermenting rods was the single significant risk factor for polyclonal bacteremia. Complications were equally frequent in all patient groups. However, patients with polyclonal bacteremia received more extensive antibiotic therapy than did patients with monoclonal bacteremia. Nearly 20% of episodes of bacteremia due to nonfermenting rods were polyclonal, but it remains unclear why nonfermenting rods were more likely to cause polyclonal bacteremia than were other gram-negative rods.
Gram-negative bacteremia is a serious infection with an estimated crude mortality rate of 20%-50% [1] . Therefore, risk factors for the development of sepsis, the natural history of the disease [2] [3] [4] [5] [6] [7] [8] [9] , and especially the therapy [10] [11] [12] [13] [14] [15] have been studied extensively. Modern molecular tools have seldom been used to study sepsis [16] [17] [18] [19] [20] [21] [22] . In some of the later studies, episodes of bacteremia due to 11 genotype of the same species have been described. Arbeit et al. [17] used the term "polyclonal bacteremia" to describe these episodes of bacteremia.
A previous retrospective study revealed that patients who had polyclonal gram-negative bacteremia more often had severe underlying conditions than did patients who had monoclonal bacteremia [23] . In addition, more patients who had polyclonal bacteremia died from bacteremia. However, the retrospective study design may have been prone to considerable bias. Therefore, we performed a prospective cohort study to estimate the frequency of polyclonal bacteremia and to investigate risk factors for and outcome of polyclonal bacteremia.
PATIENTS AND METHODS

Patients.
The Universitätsklinikum Benjamin Franklin is a 1300-bed tertiary-care hospital with ∼34,000 admissions per year. All patients were included in the study who had у1 species of aerobically growing gramnegative rod isolated from у1 blood culture collected during the period August 1996-July 1997.
One investigator, who was blind to the typing results, abstracted the following data from each patient's medical record: age, sex, hospital service where they were treated, underlying diseases, severity of underlying disease as assessed by the McCabe and Jackson criteria (rapidly fatal, expected to die within 12 months; ultimately fatal, expected to live 112 months but to die within 4 years; nonfatal, expected to live 14 years) [24] , Karnofsky score [25] , acute physiology and chronic health evaluation (APACHE II) score [26] , source of bacteremia, complications, therapy, and outcome.
Because the original study describing the APACHE II score did not include children, the score was calculated only for people aged 116 years. Data were collected on possible risk factors for bacteremia, including the following: performance of operative procedures; need for hemodialysis; presence of foreign bodies and/or placement of intravascular or urinary catheters; and need for mechanical ventilation for у24 h. A body site was considered to be the source of bacteremia if the same species of bacteria was isolated from that site and from the blood culture or if a local infection was diagnosed by means of radiology, by sonography, or during surgical procedures. The sepsis criteria defined by the consensus conference of the American College of Chest Physicians and the Society of Critical Care Medicine [27] were used to evaluate the patients' systemic responses to bacteremia. Medical records were reviewed to determine whether the patient developed any of the following complications: septic shock, adult respiratory distress syndrome, renal failure, disseminated intravascular coagulation, multiple-organ failure, or death from bacteremia. The duration of antimicrobial therapy was defined as the time period from the first day of antimicrobial therapy until the last day of therapy. For each patient, the total number of days of antibiotic therapy was calculated by adding up the duration of therapy for all the antimicrobial agents that patient received; prophylactic antimicrobial therapy was not included in the calculation.
Organisms. The microbiology laboratory (at the Universitätsklinikum Benjamin Franklin) used broth blood cultures to process blood samples (Septicheck; Becton Dickinson). From blood cultures that had grown gram-negative rods, 4 colonies of each morphologic type were further processed. The API 20E and API 20NE systems (bioMérieux) were used to identify the isolates to the species level. Isolates were stored frozen at Ϫ70ЊC in glycerin broth.
Molecular typing.
The pulsed field gel electrophoresis (PFGE) method described by Pfaller et al. [28] was used to type the isolates. After passing each isolate at least twice on blood agar, colonies were inoculated into trypticase soy broth, and the cultures were incubated overnight. The bacteria were embedded in agarose, and the chromosomal DNA was digested with the appropriate restriction enzyme: XbaI for Escherichia coli, Pseudomonas aeruginosa, and Xanthomonas maltophilia; SpeI for Enterobacter species, Klebsiella species, Proteus species, Serratia marcescens, and other Enterobacteriaceae; SmaI for Haemophilus influenzae; and AscI for Acinetobacter species. The fragments were separated by PFGE, and the gels were stained with ethidium bromide. If all major and minor bands matched exactly, the isolates were classified as identical. If at least 90% but !100% of bands matched (i.e., 1-3 bands differed), the isolates were considered to be similar. If !90% of the bands matched (i.e., 13 bands differed) the isolates were considered to be different strains. A bacteremia was defined as polyclonal if у2 different strains of the same gram-negative species were identified in a single blood culture.
Susceptibility testing. Antimicrobial susceptibility was tested by means of microbroth dilution using the break-point method. Using microtiter plates and media that we prepared (IsoSensitest bouillon; Unipath), we tested the susceptibility of isolates to the following antimicrobial agents: ampicillin, ampicillin-sulbactam, piperacillin, mezlocillin, cefotiam, cefotaxime, ceftriaxone, cefaclor, ceftazidime, imipenem, meropenem, trimethoprim-sulfamethoxazole, gentamicin, tobramycin, ofloxacin, ciprofloxacin, tetracycline, amikacin, and fosfomycin. The antibiotic resistance profiles of the strains with different PFGE types obtained from the same patient were compared. For any 2 PFGE types, a difference in the interpretive category (susceptible vs. resistant) for у1 antibiotic was required for the antibiotic profiles to be considered different.
Statistical analysis. If a patient's medical record lacked data for 140% of categories or if we were unable to type the blood culture isolates, the patient was excluded from the analysis. We used either the x 2 test or the Fisher's exact test to evaluate differences between categorical variables and the Mann-Whitney U test, to evaluate differences between continuous variables (SPSS). We set a at 0.05, and we performed 2-tailed tests.
RESULTS
During the study period, 169 patients had an episode of gramnegative bacteremia. Sixteen patients were excluded from further analysis, 9 patients because data were missing for 140% of categories, and 7 patients because we were unable to type the blood culture isolates. The patients with missing data were transferred to other hospitals shortly after a blood sample was obtained for culture; therefore, most of the data were missing in the medical records. Excluded patients were not different from included patients with respect to age, sex, hospital service where they were treated, or the microbial species that caused the episode of bacteremia.
Of the 153 patients who were included in the analysis, 47 patients had polymicrobial bacteremia. The episodes of polymicrobial bacteremia were caused by combinations of gramnegative rods and gram-positive cocci (coagulase-negative staphylococci, enterococci, or Staphylococcus aureus) in 27 patients. Some patients had polymicrobial bacteremia caused by combinations of gram-negative rods and fungi (2 patients), gram-negative rods and various anaerobic organisms (6 patients), or gram-negative and gram-positive rods (3 patients).
Nine patients had a polymicrobial bacteremia due to 2 different gram-negative species. Therefore, 162 subcultured isolates of gram-negative rods were available for typing. Escherichia coli, Klebsiella species, and Enterobacter species were the most frequently isolated gram-negative species (table 1) . Ten episodes of bacteremia (6.5%) were polyclonal-that is, the episodes were caused by 2 PFGE types of the same species. Five of the patients who had polyclonal bacteremia also had polymicrobial bacteremia. Episodes of polyclonal bacteremia were significantly more often caused by nonfermenting rods than by monoclonal or polymicrobial bacteremia.
Patients with polyclonal bacteremia were compared with patients with monoclonal bacteremia and to patients with polymicrobial bacteremia. The 5 patients who had both polymicrobial and polyclonal bacteremia were excluded from the analysis to avoid misclassification bias. Patients who had polyclonal bacteremia had the same distribution of age, sex, and number of underlying diseases as did patients who had monoclonal bacteremia and those who had polymicrobial bacteremia (table 2) . The severity and prognosis of underlying diseases were similar in all patient groups.
For all patient groups, more than one-half of the episodes of bacteremia were hospital acquired, and ∼10 were acquired during treatment in an intensive care unit. The mean duration of hospital stay before the development of bacteremia was greater for patients who had polyclonal bacteremia (17 days) than for patients who had monoclonal bacteremia (11 days) and for patients who had polymicrobial bacteremia (9 days); however, this difference was not significant. In all the patient groups, the proportion of patients who were mechanically ventilated or who had placement of a central venous or urinary catheter was similar. The urinary tract was the most frequent source of bacteremia among patients who had monoclonal or polyclonal bacteremia. Among patients who had polymicrobial bacteremia, intra-abdominal processes (e.g., diverticulitis) were the most frequent source of bacteremia.
Nearly all patients were symptomatic during their episode of bacteremia and met the criteria for sepsis (table 3). The frequency of complications during the episode of bacteremia was low in all groups of patients, and only 10 of the patients who had monoclonal bacteremia and 12 of patients who had polymicrobial bacteremia died within 7 days of the first positive blood culture. None of the patients who had polyclonal bacteremia died from bacteremia.
Patients who had polyclonal bacteremia stayed in the hospital longer after the episode than did patients with monoclonal or polymicrobial bacteremia (mean, 48 days vs. 27 days and 48 days vs. 30 days, respectively); however, this association did not reach statistical significance. Patients who had polyclonal bacteremia received more antibiotics and were treated longer than did patients who had monoclonal bacteremia. The total number of days of antibiotic therapy was significantly higher for patients who had polyclonal bacteremia than for those who had monoclonal bacteremia ( ). The antibiotic treatment did not P p .02 differ significantly between patients who had polyclonal bacteremia and patients who had polymicrobial bacteremia.
Four of 10 pairs of isolates that had different PFGE patterns also had different antimicrobial susceptibility patterns. The patterns differed in the susceptibility to 1-5 antibiotic agents. In all these cases, the microbiology laboratory had reported the susceptibility of the more resistant strain. Thus, all patients received appropriate therapy.
DISCUSSION
Frequency. To our knowledge, the frequency of polyclonal gram-negative bacteremia has not been studied before. However, several investigators have evaluated episodes of polymicrobial bacteremia [29] [30] [31] [32] [33] . Hence, the proportion of episodes of bacteremia that are polymicrobial is known to vary from 6% to 21%. However, the results of these studies are difficult to compare because the investigators used different definitions of polymicrobial bacteremia [34] . In general, most studies have defined episodes of polymicrobial bacteremia as those from which 11 species were isolated from the same blood sample. By use of this definition, a slightly higher proportion (31% [47 patients]) of our population of patients who had у1 gramnegative species isolated from blood culture had polymicrobial bacteremia.
In 9 (19%) of the 47 patients, the polymicrobial bacteremia was caused by 2 different gram-negative rods. Other investi- gators found a similar rate of bacteremia due to у2 gramnegative rods in 9%-28% of patients with polymicrobial bacteremia [30, 31, 33] . In our study population, episodes of gram-negative polyclonal bacteremia were as frequent as episodes of bacteremia due to 2 species of gram-negative rods (6.5% vs 5.8%, respectively).
Risk factors. Only few cases of polyclonal bacteremia have been reported [17, 18, 20] . Thus, no information was available on risk factors for polyclonal bacteremia. In our study population, the organism causing the bacteremia was the only significant risk factor associated with polyclonal bacteremia.
Outcome. None of the patients we studied who had polyclonal bacteremia died from the episode of bacteremia. This was not significantly different from the low mortality rate among patients who had monoclonal bacteremia and among those who had polymicrobial bacteremia. Other studies have found that patients with episodes of polymicrobial bacteremia had a higher mortality rate than did patients with episodes of monomicrobial bacteremia [29, 30] . The number of patients with documented polyclonal bacteremia still may be too low to draw conclusions on the mortality rate associated with polyclonal bacteremia.
Patients who had polyclonal bacteremia stayed in the hospital for a longer time after their episode of bacteremia and received a more extensive antibiotic therapy than did patients who had monoclonal bacteremia. However, our small group of patients did not allow us to analyze whether the longer hospital stay and the more extensive therapy resulted from polyclonal bacteremia or from the underlying disease of the patients.
Microbiology. It was striking that nearly a quarter of all episodes of bacteremia due to nonfermenting rods were polyclonal. We did not investigate the virulence factors of the causative organisms, but it seems possible that some organisms (e.g., nonfermenting rods) have special characteristics that promote the development of polyclonal bacteremia.
Nearly half of the episodes of polyclonal bacteremia were caused by bacterial strains that had different antimicrobial susceptibility profiles. In other reports of polyclonal infections, paired isolates from one-half of patients also had different antimicrobial susceptibility patterns [17] [18] [19] [20] [21] [22] . Therefore, the laboratory practice of identifying and testing isolates with different morphologic types from the same blood culture clearly has merit. If microbiologists test only 1 susceptible strain isolated from a patient with an episode of polyclonal bacteremia, the therapy that follows may select for the resistant strain. This could be misconstrued as the development of resistance during antibiotic therapy, even though de novo acquisition of resistance is a rare incident, occurring in !10% of relapses [35] .
In conclusion, polyclonal bacteremia may be more similar to polymicrobial bacteremia than to monoclonal bacteremia with respect to outcome. Therefore, in further studies of the outcome of bacteremia, patients who have polyclonal bacteremia may have to be analyzed separately.
